University of Groningenfounded in 1614  -  top 100 university
Close
About usHow to find usdr. A.H. Brouwers

dr. A.H. Brouwers

Research

Research units:

Advanced
Advanced

Reset

to
1 - 50 out of 128Page size: 50
  1. 2019
  2. de Hosson, L. D., van der Loo-van der Schaaf, A. M., Boellaard, R., van Snick, J. H., de Vries, E. G. E., Brouwers, A. H., & Walenkamp, A. M. E. (2019). Interlesional Heterogeneity of Metastatic Neuroendocrine Tumors Based on 18F-DOPA PET/CT. Clinical Nuclear Medicine, 44(8), 612-619. https://doi.org/10.1097/RLU.0000000000002640
  3. Jauw, Y. W. S., Bensch, F., Brouwers, A. H., Hoekstra, O. S., Zijlstra, J. M., Pieplenbosch, S., ... Huisman, M. C. (2019). Interobserver reproducibility of tumor uptake quantification with Zr-89-immuno-PET: a multicenter analysis. European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1840-1849. https://doi.org/10.1007/s00259-019-04377-6
  4. Verhoeff, S. R., van Es, S. C., Boon, E., van Helden, E., Angus, L., Elias, S. G., ... van Herpen, C. M. L. (2019). Lesion detection by [Zr-89]Zr-DFO-girentuximab and [F-18]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma. European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1931-1939. https://doi.org/10.1007/s00259-019-04358-9
  5. Noltes, M. E., Kruijff, S., Noordzij, W., Telenga, E. D., Vállez García, D., Trofimiuk-Müldner, M., ... Brouwers, A. H. (2019). Optimization of parathyroid C-11-choline PET protocol for localization of parathyroid adenomas in patients with primary hyperparathyroidism. EJNMMI Research, 9(1), [73]. https://doi.org/10.1186/s13550-019-0534-5
  6. den Toom, I. J., Boeve, K., van Weert, S., Bloemena, E., Brouwers, A. H., Hoekstra, O. S., ... de Bree, R. (2019). High rate of unexpected lymphatic drainage patterns and a high accuracy of the sentinel lymph node biopsy in oral cancer after previous neck treatment. Oral Oncology, 94, 68-72. https://doi.org/10.1016/j.oraloncology.2019.05.007
  7. Holvast, A., Kats-Ugurlu, G., Bodewes, F. A. J. A., de Kleine, R. H. J., Porte, R. J., Brouwers, A. H., & van der Doef, H. P. J. (2019). Reversal of secondary protein-losing enteropathy after surgical revision of a jejunal Roux-en-Y loop in a patient after liver transplantation. American Journal of Transplantation, 19(7), 2116-2121. https://doi.org/10.1111/ajt.15354
  8. Moek, K. L., Waaijer, S. J. H., Kok, I. C., Suurs, F. V., Brouwers, A. H., Menke-van der Houven van Oordt, C. W., ... de Vries, E. G. (2019). Zr-89-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor Uptake. Clinical Cancer Research, 25(12). https://doi.org/10.1158/1078-0432.CCR-18-2918
  9. Boeve, K., Den Toom, I. J., Van Weert, S., Bloemena, E., Brouwers, A. H., Hoekstra, O. S., ... De Bree, R. (2019). Unexpected drainage patterns and high accuracy of SLNB in OSCC after previous neck treatment. Radiotherapy and Oncology, 132(Suppl.1), 13-14. [OC-022]. https://doi.org/10.1016/S0167-8140(19)30188-4
  10. Dutch Pediat Thyroid Canc Study Co, Selvakumar, T., Nies, M., Hesselink, M. S. K., Brouwers, A. H., van der Horst-Schrivers, A. N. A., ... Links, T. P. (2019). Long-term effects of radioiodine treatment on salivary gland function in adult survivors of pediatric differentiated thyroid carcinoma. Journal of Nuclear Medicine, 60(2), 172-177. https://doi.org/10.2967/jnumed.118.212449
  11. Eisses, B., Angus, L., van der Vegt, B., Sieuwerts, A. M., Kraan, J., Martens, J. W., ... Schroder, C. P. (2019). Non-invasive estrogen receptor assessment by [F-18]-fluorestradiol(FES)-PET or circulating tumor cells predicts receptor status in patients with metastatic breast cancer. Cancer Research, 79(4). https://doi.org/10.1158/1538-7445.SABCS18-PD4-09
  12. Dekker, B. L., van der Horst-Schrivers, A. N. A., Sluiter, W. J., Brouwers, A. H., Lentjes, E. G. W. M., Heijboer, A. C., ... Links, T. P. (2019). Clinical Applicability of Low Levels of Thyroglobulin Autoantibodies as Cutoff Point for Thyroglobulin Autoantibody Positivity. Thyroid, 29(1), 71-78. https://doi.org/10.1089/thy.2018.0195
  13. 2018
  14. Bensch, F., van der Veen, E. L., Lub-de Hooge, M. N., Jorritsma-Smit, A., Boellaard, R., Kok, I. C., ... de Vries, E. G. E. (2018). Zr-89-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer. Nature Medicine, 24(12), 1852-1858. https://doi.org/10.1038/s41591-018-0255-8
  15. Bensch, F., Brouwers, A. H., Lub-de Hooge, M. N., de Jong, J. R., van der Vegt, B., Sleijfer, S., ... Schröder, C. P. (2018). 89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up. European Journal of Nuclear Medicine and Molecular Imaging, 45(13), 2300-2306. https://doi.org/10.1007/s00259-018-4099-8
  16. de Heer, E. C., Brouwers, A. H., Boellaard, R., Sluiter, W. J., Diercks, G. F. H., Hospers, G. A. P., ... Jalving, M. (2018). Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative F-18-FDG PET/CT analysis. EJNMMI Research, 8(1), [101]. https://doi.org/10.1186/s13550-018-0453-x
  17. Noltes, M. E., Kruijf, S., Noordzij, W., Telenga, E., Vállez García, D., Trofmiuk-Müldner, M., ... Brouwers, A. H. (2018). Optimization of 11C-choline positron emission tomography protocol for localization of parathyroid adenomas in patients with primary hyperparathyroidism. European Journal of Nuclear Medicine and Molecular Imaging, 45, 89. https://doi.org/10.1007/s00259-018-4148-3
  18. Verhoeff, S. R., Es, S., Boon, E., van Helden, E., Angus, L., Elias, S., ... van Herpen, C. M. L. (2018). Lesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC). Annals of Oncology, 29(Suppl.8), viii314-viii315. [888P]. https://doi.org/10.1093/annonc/mdy283.097
  19. Moek, K. L., Waaijer, S. J. H., Kok, I. C., Suurs, F. V., Brouwers, A., van Oordt, C. W. M. D. H., ... de Vries, E. G. E. (2018). Zirconium-89 (89Zr)-labeled bispecific T-cell engager (BiTE (R)) AMG 211 PET imaging to determine AMG 211 biodistribution in patients with gastrointestinal (GI) adenocarcinomas. Annals of Oncology, 29(Suppl.8).
  20. Berends, A. M. A., Kerstens, M. N., Bolt, J. W., Links, T. P., Korpershoek, E., de Krijger, R. R., ... van der Horst-Schrivers, A. N. A. (2018). False-positive findings on 6-[18F]fluor-L-3,4-dihydroxyphenylalanine PET (F-18-FDOPA-PET) performed for imaging of neuroendocrine tumors. European Journal of Endocrinology, 179(2), 125-133. https://doi.org/10.1530/EJE-18-0321
  21. Boeve, K., Schepman, K. P., Schuuring, E., Roodenburg, J. L. N., Halmos, G. B., van Dijk, B. A. C., ... Witjes, M. J. H. (2018). High sensitivity and negative predictive value of sentinel lymph node biopsy in a retrospective early stage oral cavity cancer cohort in the Northern Netherlands. Clinical Otolaryngology, 43(4), 1080-1087. https://doi.org/10.1111/coa.13107
  22. Stevenson, M. G., Been, L. B., Hoekstra, H. J., Suurmeijer, A. J. H., Boellaard, R., & Brouwers, A. H. (2018). Volume of interest delineation techniques for F-18-FDG PET-CT scans during neoadjuvant extremity soft tissue sarcoma treatment in adults: a feasibility study. EJNMMI Research, 8(1), [42]. https://doi.org/10.1186/s13550-018-0397-1
  23. Stevenson, M. G., Seinen, J. M., Pras, E., Brouwers, A. H., van Ginkel, R. J., van Leeuwen, B. L., ... Hoekstra, H. J. (2018). Hyperthermic isolated limb perfusion, preoperative radiotherapy, and surgery (PRS) a new limb saving treatment strategy for locally advanced sarcomas. Journal of Surgical Oncology, 117(7), 1447-1454. https://doi.org/10.1002/jso.25008
  24. Holvast, B., Bodewes, F. A. J. A., De Kleine, R. H. J., Porte, R. J., Brouwers, A. H., Kats-Ugurlu, G., & Van Der Doef, H. P. J. (2018). Roux loop revision for treatment of focal protein losing enteropathy in the Roux-Y loop after liver transplantation. Journal of Pediatric Gastroenterology and Nutrition, 66, 699-700.
  25. Brouwers, A. (2018). De IMPACT-studies: molecular imaging met PET tracers in de oncologie. Tijdschrift voor Nucleaire Geneeskunde, 40(1), 1900.
  26. Nies, M., Dekker, B. L., Sulkers, E., Huizinga, G. A., Klein Hesselink, M., Maurice-Stam, H., ... Links, T. P. (2018). Psychosocial development in survivors of childhood differentiated thyroid carcinoma: a cross-sectional study. European Journal of Endocrinology, 178(3), 215-223. https://doi.org/10.1530/EJE-17-0741
  27. Waaijer, S. J. H., Kok, I. C., Eisses, B., Schröder, C. P., Jalving, M., Brouwers, A. H., ... de Vries, E. G. E. (2018). Molecular Imaging in Cancer Drug Development. Journal of Nuclear Medicine, 59(5), 726-732. https://doi.org/10.2967/jnumed.116.188045
  28. Bensch, F., Smeenk, M. M., van Es, S. C., de Jong, J. R., Schröder, C. P., Oosting, S. F., ... de Vries, E. G. E. (2018). Comparative biodistribution analysis across four different Zr-monoclonal antibody tracers-The first step towards an imaging warehouse. Theranostics, 8(16), 4295-4304. https://doi.org/10.7150/thno.26370
  29. Brouwers, A., Links, T., & Piers, DA. (2018). De behandeling van het schildkliercarcinoom met jodium-131. Verleden, heden en toekomst. Theranostics avant la lettre. Tijdschrift voor Nucleaire Geneeskunde, 40(4), 2079-2084.
  30. Pfaehler, E., Burggraaff, C., Kramer, G., Zijlstra, J., Hoekstra, OS., Jalving, M., ... Boellaard, R. (2018). PET segmentation of bulky tumors: inter-observer variability of four segmentation approaches. European Journal of Nuclear Medicine and Molecular Imaging, 45, S44.
  31. 2017
  32. Hesselink, M. S. K., Bocca, G., Hummel, Y. M., Brouwers, A. H., Burgerhof, J. G. M., van Dam, E. W. C. M., ... Tissing, W. J. E. (2017). Diastolic Dysfunction is Common in Survivors of Pediatric Differentiated Thyroid Carcinoma. Thyroid, 27(12), 1481-1489. https://doi.org/10.1089/thy.2017.0383
  33. Noltes, M. E., Coester, A. M., van der Horst-Schrivers, A. N. A., Dorgelo, B., Jansen, L., Noordzij, W., ... Kruijff, S. (2017). Localization of parathyroid adenomas using 11C-methionine pet after prior inconclusive imaging. Langenbecks Archives of Surgery, 402(7), 1109-1117. https://doi.org/10.1007/s00423-017-1549-x
  34. Bensch, F., Lamberts, L. E., Smeenk, M. M., Jorritsma-Smit, A., Lub-de Hooge, M. N., Terwisscha van Scheltinga, A. G. T., ... de Vries, E. G. (2017). Zr-89-Lumretuzumab PET Imaging before and during HER3 Antibody Lumretuzumab Treatment in Patients with Solid Tumors. Clinical Cancer Research, 23(20), 6128-6137. https://doi.org/10.1158/1078-0432.CCR-17-0311
  35. Schreuder, R. S. B. H., Brouwers, A. H., Elsinga, P. H., Slart, R. H. J. A., Walenkamp, A. M. E., Glaudemans, A. W. J. M., & Luurtsema, G. (2017). Quantification of 6-[F-18]fluoro-L-3,4-dihydroxyphenyl alanine Uptake in Neuroendocrine Tumour Lesions: The Effect of Specific Activity. European Journal of Nuclear Medicine and Molecular Imaging, 44, S691-S692.
  36. Moek, K. L., Giesen, D., Kok, I. C., de Groot, D. J. A., Jalving, M., Fehrmann, R. S. N., ... de Vries, E. G. E. (2017). Theranostics Using Antibodies and Antibody-Related Therapeutics. Journal of Nuclear Medicine, 58(Suppl 2), 83S-90S. https://doi.org/10.2967/jnumed.116.186940
  37. Klein Hesselink, E. N., Horst-Schrivers, van der, A., van der Horst, I. C. C., Bakker, S. J. L., Muller Kobold, A. C., Brouwers, A. H., ... Lefrandt, J. D. (2017). NT-proBNP is increased in differentiated thyroid carcinoma patients and may predict cardiovascular risk. Clinical biochemistry, 50(12), 696-702. https://doi.org/10.1016/j.clinbiochem.2017.02.020
  38. Bensch, F., van der Veen, E., Jorritsma, A., Lub-de Hooge, M., Boellaard, R., Oosting, S., ... de Vries, E. (2017). First-in-human PET imaging with the PD-L1 antibody Zr-89-atezolizumab. Cancer Research, 77. https://doi.org/10.1158/1538-7445.AM2017-CT017
  39. van Es, S. C., Brouwers, A. H., Mahesh, S. V. K., Leliveld-Kors, A. M., de Jong, I. J., Lub-de Hooge, M. N., ... Oosting, S. F. (2017). 89Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma. Journal of Nuclear Medicine, 58(6), 905-910. https://doi.org/10.2967/jnumed.116.183475
  40. Nies, M., Klein Hesselink, M. S., Huizinga, G. A., Sulkers, E., Brouwers, A. H., Burgerhof, J. G. M., ... Bocca, G. (2017). Long-Term Quality of Life in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma. Journal of Clinical Endocrinology and Metabolism, 102(4), 1218-1226. https://doi.org/10.1210/jc.2016-2246
  41. Groen, A. H., Klein Hesselink, M., Plukker, J., Sluiter, W. J., Horst-Schrivers, van der, A., Brouwers, A. H., ... Links, T. P. (2017). Additional value of a high sensitive thyroglobulin assay in the follow-up of patients with differentiated thyroid carcinoma. Clinical Endocrinology, 86(3), 419-424. https://doi.org/10.1111/cen.13180
  42. Boeve, K., Schepman, K-P., van der Vegt, B., Schuuring, E., Roodenburg, J. L., Brouwers, A. H., & Witjes, M. J. (2017). Lymphatic drainage patterns of oral maxillary tumors: Approachable locations of sentinel lymph nodes mainly at the cervical neck level. Journal of the Sciences and Specialties of the Head and Neck, 39(3), 486-491. https://doi.org/10.1002/hed.24628
  43. Schroder, C. P., Bensch, F., Brouwers, A. H., Lub-de Hooge, M. N., de Jong, J. R., van der Vegt, B., ... de Vries, E. G. (2017). Clinical value of Zr-89-trastuzumab PET in HER2-positive breast cancer patients with a clinical dilemma. Cancer Research, 77(4). https://doi.org/10.1158/1538-7445.SABCS16-P5-03-06
  44. van der Plas, W. Y., Noltes, M. E., Schaeffers, A. W. M. A., Brouwers, A. H., van der Horst-Schrivers, A. N. A., & Kruijff, S. (2017). De diagnostiek en behandeling van primaire hyperparathyreoïdie. Nederlands Tijdschrift voor Geneeskunde, 161(0), [D1870].
  45. 2016
  46. Klein Hesselink, E., Brouwers, A. H., Jong, de, J. R., van der Horst-Schrivers, A. N. A., Coppes, R. P., Lefrandt, J. D., ... Links, T. P. (2016). Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study. Journal of Nuclear Medicine, 57(11), 1685-1691. https://doi.org/10.2967/jnumed.115.169888
  47. Ebben, C. W. J., & Brouwers, A. (2016). Richtlijn Melanoom: Modulaire revisie 2016. Nederlands Tijdschrift voor Oncologie, 13(6), 218-220.
  48. Oosting, S. F., van Asselt, S. J., Brouwers, A. H., Bongaerts, A. H. H., Steinberg, J. D. J., de Jong, J., ... Links, T. P. (2016). Zr-89-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel-Lindau Disease. Journal of Nuclear Medicine, 57(8), 1244-1250. https://doi.org/10.2967/jnumed.115.167643
  49. Kist, J. W., de Keizer, B., van der Vlies, M., Brouwers, A. H., Huysmans, D. A., van der Zant, F. M., ... THYROPET Study Grp (2016). I-124 PET/CT to Predict the Outcome of Blind I-131 Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer: Results of a Multicenter Diagnostic Cohort Study (THYROPET). Journal of Nuclear Medicine, 57(5), 701-707. https://doi.org/10.2967/jnumed.115.168138
  50. Klein Hesselink, M. S., Nies, M., Bocca, G., Brouwers, A. H., Burgerhof, J. G. M., van Dam, E. W. C. M., ... Links, T. P. (2016). Pediatric Differentiated Thyroid Carcinoma in The Netherlands: A Nationwide Follow-Up Study. Journal of Clinical Endocrinology and Metabolism, 101(5), 2031-2039. https://doi.org/10.1210/jc.2015-3290
  51. van Asselt, S. J., Brouwers, A. H., van Dullemen, H. M., van der Jagt, E. J., Bongaerts, A. H., Koopmans, K. P., ... Links, T. P. (2016). Potential value of EUS in pancreatic surveillance of VHL patients. European Journal of Endocrinology, 174(5), 611-620. https://doi.org/10.1530/EJE-15-1012
  52. Niebling, M. G., Pleijhuis, R. G., Bastiaannet, E., Brouwers, A. H., van Dam, G. M., & Hoekstra, H. (2016). A systematic review and meta-analyses of sentinel lymph node identification in breast cancer and melanoma, a plea for tracer mapping. European Journal of Surgical Oncology, 42(4), 466-473. https://doi.org/10.1016/j.ejso.2015.12.007
  53. Gebhart, G., Lamberts, L. E., Wimana, Z., Garcia, C., Emonts, P., Ameye, L., ... Flamen, P. (2016). Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial. Annals of Oncology, 27(4), 619-624. https://doi.org/10.1093/annonc/mdv577
  54. Reyners, A. K. L., Broekman, K. E., Glaudemans, A. W. J. M., Brouwers, A. H., Arts, H. J. G., van der Zee, A. G. J., ... Jalving, M. (2016). Molecular imaging in ovarian cancer. Annals of Oncology, 27 (Supplement 1), i23-i29. https://doi.org/10.1093/annonc/mdw091
Previous 1 2 3 Next

ID: 324562

University of Groningen staff: edit these data

print
Follow the UGfacebook twitter linkedin rss instagram youtube